Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study

被引:150
|
作者
Davis, RN [1 ]
Massman, PJ
Doody, RS
机构
[1] Univ Houston, Dept Psychol, Houston, TX 77204 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源
关键词
Alzheimer disease; cognitive intervention; dementia; neuropsychology;
D O I
10.1097/00002093-200101000-00001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The efficacy of a cognitive intervention consisting of training in face-name associations, spaced retrieval, and cognitive stimulation was tested in a sample of 37 patients (16 men, 21 women) with probable Alzheimer disease (AD). Patients with AD were randomly assigned to receive either the cognitive intervention or a mock (placebo) intervention for 5 weeks. The placebo group then crossed over to receive the intervention. During the intervention, AD patients showed significant improvement in recall of personal information, face-name recall, and performance on the Verbal Series Attention Test. Improvement did not generalize to additional neuropsychologic measures of dementia severity, verbal memory, visual memory, word generation, or motor speed, or to caregiver-assessed patient quality of life. Results suggest that although face-name training, spaced retrieval, and cognitive stimulation may produce small gains in learning personal information and on a measure of attention, improvement does not generalize to overall neuropsychologic functioning or patient quality of life.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [1] A randomized, placebo-controlled study of the efficacy of cognitive intervention on elderly people and on patient's with Alzheimer's disease
    Yanguas, J. J.
    Buiza, C.
    Etxeberria, I.
    Galdona, N.
    Gonzalez, M. F.
    Urdaneta, E.
    COMPUTERS HELPING PEOPLE WITH SPECIAL NEEDS, PROCEEDINGS, 2006, 4061 : 759 - 765
  • [2] SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study
    Maher-Edwards, Gareth
    Dixon, Ruth
    Hunter, Jackie
    Gold, Michael
    Hopton, Gillian
    Jacobs, Gemma
    Hunter, Jo
    Williams, Pauline
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (05) : 536 - 544
  • [3] Aripiprazole for the treatment of psychosis in patients with Alzheimer's Disease - A randomized, placebo-controlled study
    De Deyn, P
    Jeste, DV
    Swanink, R
    Kostic, D
    Breder, C
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 463 - 467
  • [4] Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
    Herrmann, Nathan
    Ruthirakuhan, Myuri
    Gallagher, Damien
    Verhoeff, Nicolaas Paul L. G.
    Kiss, Alex
    Black, Sandra E.
    Lanctot, Krista L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (11): : 1161 - 1173
  • [5] Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease
    Hager, Klaus
    Baseman, Alan S.
    Nye, Jeffrey S.
    Brashear, H. Robert
    Han, John
    Sano, Mary
    Davis, Bonnie
    Richards, Henry M.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 391 - 401
  • [6] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
  • [7] Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial
    Gibson, Gary E.
    Luchsinger, Jose A.
    Cirio, Rosanna
    Chen, Huanlian
    Franchino-Elder, Jessica
    Hirsch, Joseph A.
    Bettendorff, Lucien
    Chen, Zhengming
    Flowers, Sarah A.
    Gerber, Linda M.
    Grandville, Thomas
    Schupf, Nicole
    Xu, Hui
    Stern, Yaakov
    Habeck, Christian
    Jordan, Barry
    Fonzetti, Pasquale
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (03) : 989 - 1010
  • [8] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
    Turner, R. Scott
    Thomas, Ronald G.
    Craft, Suzanne
    van Dyck, Christopher H.
    Mintzer, Jacobo
    Reynolds, Brigid A.
    Brewer, James B.
    Rissman, Robert A.
    Raman, Rema
    Aisen, Paul S.
    NEUROLOGY, 2015, 85 (16) : 1383 - 1391
  • [9] Initial Findings of a Randomized Double-Blinded Placebo-Controlled Study of Intravenous Immunoglobulin in Mild Cognitive Impairment Due to Alzheimer Disease
    Kile, Shawn
    Au, William
    Parise, Carol
    Low, Renee
    NEUROLOGY, 2013, 80
  • [10] A RANDOMIZED, PLACEBO-CONTROLLED PILOT STUDY OF MONTELUKAST IN CELIAC DISEASE
    Kupfer, Sonia S.
    Mayassi, Toufic
    Setia, Namrata
    Semrad, Carol E.
    Jabri, Bana
    GASTROENTEROLOGY, 2018, 154 (06) : S491 - S491